CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 17 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00263-07v1
14/12/1563    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrington, N. P.
Right arrow Articles by Prescott, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrington, N. P.
Right arrow Articles by Prescott, J. F.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00263-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Development and evaluation of a multi-species real-time RT-PCR assay for interferon-gamma mRNA detection of tuberculosis infection

Noel P. Harrington*, Om P. Surujballi, W. Ray Waters, and John F. Prescott

Canadian Food Inspection Agency, Ottawa Laboratory Fallowfield, Ottawa, Ontario, Canada; Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada; National Animal Disease Center, United States Department of Agriculture, Ames, IA, USA

* To whom correspondence should be addressed. Email: harringtonnp{at}inspection.gc.ca.


   Abstract

Tuberculosis of free-ranging and captive wildlife, including species implicated in the maintenance and transmission of Mycobacterium bovis, is a difficult disease to diagnose and control. Historically, diagnosis of tuberculosis has relied largely upon assays of cell-mediated immunity (CMI) such as tuberculin skin testing. This approach, however, is problematic or impractical for many wildlife species. Increasingly, in vitro diagnostic tests including interferon-gamma (IFN-{gamma}) based assays, are replacing or complementing skin testing of cattle and humans. Analogous assays are unavailable for most wildlife because of a lack of species-specific immunological reagents. This report describes the development and validation of a whole blood assay to quantify antigen-specific IFN-{gamma} mRNA expression by quantitative real-time RT-PCR. Oligonucleotide primers and probes were designed and tested for reactivity towards several susceptible species of interest with respect to tuberculosis infection. The assay was subsequently optimized to quantify elk and red deer (Cervus elaphus) IFN-{gamma} mRNA expression and was evaluated for its ability to detect mycobacterial antigen-specific responses of experimentally tuberculosis-infected animals. The assay was a simple, rapid, and sensitive measure of antigen specific CMI. The IFN-{gamma} mRNA responses correlated well with IFN-{gamma} protein production and showed superior performance in determining an animal's infection status over either lymphocyte proliferation or IFN-{gamma} protein ELISA methods. An additional advantage is the ease with which the assay can be modified to reliably quantify the IFN-{gamma} expression using consensus sequences of closely related species or of other species for which IFN-{gamma} sequence information is available.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.